HER2+ Breast Cancer Neo-Adjuvant Coordination of Care Program

Completed

Conditions studied: Breast Cancer

In brief

Currently many patients with HER2+ Breast Cancer do not have the opportunity to be evaluated by a medical oncologist for neo-adjuvant treatment due to the current lack of care coordination between the surgeon/surgical oncologist and the medical oncologists. This project will evaluate the feasibility to enhance knowledge that drives adoption of evidence based care, and evaluate the improvement in care coordination between oncologists and surgeons for patients with HER2+ Breast Cancer in the Neo-Adjuvant setting.

Key facts

Study ID

NCT02616133

Run by

Duke University

People needed

30

Starts

2016-01-01

Expected to finish

2017-03-31

Last updated by the study team

2017-07-02

Who can join

Age: any. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• diagnosis of breast cancer

You may not qualify if…

• no diagnosis of breast cancer

Where it is running

• Marquette General Hospital — Marquette, Michigan, United States
• DLP Maria Parham Medical Center — Henderson, North Carolina, United States
• Lexington Medical Center — West Columbia, South Carolina, United States
• Augusta Health — Fishersville, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.